| Title | Present and future of clinical cardiovascular PET imaging in Europe-a position statement by the European Council of Nuclear Cardiology (ECNC). | | Author(s) | Le Guludec D, Lautamäki R, Knuuti J, Bax JJ, Bengel FM, on behalf of the European Council of Nuclear Cardiology (ECNC) | | Institution | Department of Nuclear Medicine, Bichat Hospital, Paris, France, ecnc-office@vereint.com. | | Source | Eur J Nucl Med Mol Imaging 2008 Jul 3. | | Abstract | Introduction: This position statement was prepared by the European Council of Nuclear Cardiology (ECNC) and summarizes the current and future potential of positron emission tomography (PET) as a clinical cardiovascular diagnostic imaging tool. A first section describes how methodological developments have positively influenced the transition of PET from a research tool towards a clinical diagnostic test. In a second section, evidence in support of its superior diagnostic accuracy, its value to guide decision making and to predict outcome, and its cost-effectiveness is summarized. A third section finally outlines new PET-based approaches and concepts which will likely influence clinical cardiovascular medicine in the future.
Conclusion: The notion that integration of cardiac PET into healthcare systems and disease management algorithms will advance quality of care is increasingly supported by the literature highlighted in this statement. | | Language | ENG | | Pub Type(s) | JOURNAL ARTICLE
| | PubMed ID | 18597085 |
|
